Revenue and Profitability - Revenue for the three months ended September 30, 2024, was 51,140,adecreaseof65,612 or 56% compared to 116,752inthesameperiodof2023[68]−NetlossforthethreemonthsendedSeptember30,2024,was1,195, compared to net income of 2,776inthesameperiodof2023,representingadecreaseof3,971[68] - Adjusted EBITDA for the three months ended September 30, 2024, was (973),adecreaseof10,632 compared to 9,659inthesameperiodof2023[68]−RevenuefortheninemonthsendedSeptember30,2024,was181,830, down 94,411or34276,241 in the same period of 2023[70] - Gross profit for the three months ended September 30, 2024, decreased to 383,down3,487 or 90.1% from 3,870inthesameperiodof2023[79]−GrossprofitfortheninemonthsendedSeptember30,2024,decreasedby9,812 or 44.8% compared to the same period in 2023, primarily due to reduced RIN sales and higher costs from extreme winter weather[82][86] Segment Performance - The biofuel segment experienced a sales volume decline of 41,015inthethreemonthsendedSeptember30,2024,primarilyduetoproductionissuesanddelaysfromequipmentsuppliers[79]−Thechemicalsegmentsawaslightrevenueincreaseof81 in the three months ended September 30, 2024, driven by stronger sales volumes in the coatings market[79] - Chemical segment revenues for the nine months ended September 30, 2024, decreased by 3,261or5.646,333, a decrease of 317[89]−BiofuelsegmentrevenuesfortheninemonthsendedSeptember30,2024,decreasedby91,150 or 41.9% compared to the same period in 2023, primarily due to a 22% reduction in sales volume and a 20% reduction in average price[93] - Gross loss for the biofuel segment in the three months ended September 30, 2024, was 3,024,adecreaseof16 from the same period in 2023, attributed to reduced sales volumes and production issues[95] Operating Expenses and Tax - Operating expenses for the three months ended September 30, 2024, were (3,271),adecreaseof302 or 8.5% compared to (3,573)inthesameperiodof2023[79]−Operatingexpensesdecreasedby650 in the nine months ended September 30, 2024, compared to the same period in 2023, driven by lower administrative and research and development expenses[83] - The income tax benefit provision for the nine months ended September 30, 2024, was 635,anincreaseof1767.634 in the same period of 2023[79] - The company’s income tax benefit was insignificant in the three months ended September 30, 2024, with no deferred tax benefits recognized due to management's assessment of deferred tax assets[86][87] - The company evaluates its deferred tax assets quarterly and records a valuation allowance to reduce these assets to realizable amounts[87] Cash Flow and Financing - Cash provided by operating activities increased to 41,415,a3888,458 in the same period of 2023[107] - Cash used in investing activities was 10,176,adecreaseof39,892 compared to cash provided by investing activities of 29,716intheninemonthsendedSeptember30,2023[108]−Cashusedinfinancingactivitiesroseto117,285, primarily due to dividend payments, including a special dividend of 109,408[109]−Aspecialdividendof2.50 per share was paid on April 9, 2024, totaling 109,408,withregularcashdividendsof0.06 per share paid quarterly[113] - The company has a credit agreement for 100,000,whichisarevolvingfacilitysettoterminateonMarch30,2025[111]MarketandRiskFactors−Thefairvalueofderivativeinstrumentswasanetassetof297 as of September 30, 2024, down from 1,736atDecember31,2023[122]−Ahypothetical109,664, representing a 68.8% decrease[126] - The company intends to fund future capital requirements from cash flow, existing cash, and potential borrowings under the credit facility, without the need to issue securities[112] - The company has no borrowings as of September 30, 2024, indicating no exposure to interest rate risk[127] - Market risks include commodity price fluctuations, with significant risks associated with raw materials such as yellow grease and used cooking oil[120]